vs

Side-by-side financial comparison of Autodesk (ADSK) and ResMed (RMD). Click either name above to swap in a different company.

Autodesk is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× ResMed). ResMed runs the higher net margin — 27.6% vs 16.1%, a 11.4% gap on every dollar of revenue. On growth, Autodesk posted the faster year-over-year revenue change (19.4% vs 11.0%). Over the past eight quarters, Autodesk's revenue compounded faster (17.5% CAGR vs 7.9%).

Autodesk, Inc. is an American multinational software corporation that provides software products and services for the architecture, engineering, construction, manufacturing, media, education, and entertainment industries. Autodesk is headquartered in San Francisco, California, and has offices worldwide. Its U.S. offices are located in the states of California, Oregon, Colorado, Texas, Michigan, New Hampshire and Massachusetts.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

ADSK vs RMD — Head-to-Head

Bigger by revenue
ADSK
ADSK
1.4× larger
ADSK
$2.0B
$1.4B
RMD
Growing faster (revenue YoY)
ADSK
ADSK
+8.4% gap
ADSK
19.4%
11.0%
RMD
Higher net margin
RMD
RMD
11.4% more per $
RMD
27.6%
16.1%
ADSK
Faster 2-yr revenue CAGR
ADSK
ADSK
Annualised
ADSK
17.5%
7.9%
RMD

Income Statement — Q4 FY2026 vs Q4 FY2026

Metric
ADSK
ADSK
RMD
RMD
Revenue
$2.0B
$1.4B
Net Profit
$316.0M
$392.6M
Gross Margin
91.5%
61.8%
Operating Margin
22.0%
34.6%
Net Margin
16.1%
27.6%
Revenue YoY
19.4%
11.0%
Net Profit YoY
4.3%
13.9%
EPS (diluted)
$1.47
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADSK
ADSK
RMD
RMD
Q2 26
$1.4B
Q1 26
$2.0B
Q4 25
$1.9B
$1.4B
Q3 25
$1.8B
$1.3B
Q2 25
$1.6B
$1.3B
Q1 25
$1.6B
$1.3B
Q4 24
$1.6B
$1.3B
Q3 24
$1.5B
$1.2B
Net Profit
ADSK
ADSK
RMD
RMD
Q2 26
$392.6M
Q1 26
$316.0M
Q4 25
$343.0M
$392.6M
Q3 25
$313.0M
$348.5M
Q2 25
$152.0M
$379.7M
Q1 25
$303.0M
$365.0M
Q4 24
$275.0M
$344.6M
Q3 24
$282.0M
$311.4M
Gross Margin
ADSK
ADSK
RMD
RMD
Q2 26
61.8%
Q1 26
91.5%
Q4 25
91.1%
61.8%
Q3 25
91.0%
61.5%
Q2 25
90.2%
60.8%
Q1 25
90.6%
59.3%
Q4 24
90.6%
58.6%
Q3 24
90.7%
58.6%
Operating Margin
ADSK
ADSK
RMD
RMD
Q2 26
34.6%
Q1 26
22.0%
Q4 25
25.4%
34.6%
Q3 25
25.2%
33.4%
Q2 25
14.3%
33.7%
Q1 25
22.3%
33.0%
Q4 24
22.0%
32.5%
Q3 24
22.8%
31.6%
Net Margin
ADSK
ADSK
RMD
RMD
Q2 26
27.6%
Q1 26
16.1%
Q4 25
18.5%
27.6%
Q3 25
17.8%
26.1%
Q2 25
9.3%
28.2%
Q1 25
18.5%
28.3%
Q4 24
17.5%
26.9%
Q3 24
18.7%
25.4%
EPS (diluted)
ADSK
ADSK
RMD
RMD
Q2 26
$2.68
Q1 26
$1.47
Q4 25
$1.60
$2.68
Q3 25
$1.46
$2.37
Q2 25
$0.70
$2.58
Q1 25
$1.39
$2.48
Q4 24
$1.27
$2.34
Q3 24
$1.30
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADSK
ADSK
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$2.6B
$1.4B
Total DebtLower is stronger
$2.5B
$663.8M
Stockholders' EquityBook value
$3.0B
$6.3B
Total Assets
$12.5B
$8.5B
Debt / EquityLower = less leverage
0.82×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADSK
ADSK
RMD
RMD
Q2 26
$1.4B
Q1 26
$2.6B
Q4 25
$2.3B
$1.4B
Q3 25
$2.2B
$1.4B
Q2 25
$2.0B
$1.2B
Q1 25
$1.9B
$932.7M
Q4 24
$1.7B
$521.9M
Q3 24
$1.9B
$426.4M
Total Debt
ADSK
ADSK
RMD
RMD
Q2 26
$663.8M
Q1 26
$2.5B
Q4 25
$2.5B
$403.9M
Q3 25
$2.5B
$408.7M
Q2 25
$2.3B
$658.4M
Q1 25
$2.3B
$663.1M
Q4 24
$2.3B
$662.9M
Q3 24
$2.3B
$667.6M
Stockholders' Equity
ADSK
ADSK
RMD
RMD
Q2 26
$6.3B
Q1 26
$3.0B
Q4 25
$2.9B
$6.3B
Q3 25
$2.7B
$6.1B
Q2 25
$2.6B
$6.0B
Q1 25
$2.6B
$5.5B
Q4 24
$2.6B
$5.3B
Q3 24
$2.5B
$5.2B
Total Assets
ADSK
ADSK
RMD
RMD
Q2 26
$8.5B
Q1 26
$12.5B
Q4 25
$11.2B
$8.5B
Q3 25
$10.9B
$8.3B
Q2 25
$10.6B
$8.2B
Q1 25
$10.8B
$7.6B
Q4 24
$10.1B
$7.1B
Q3 24
$10.0B
$7.2B
Debt / Equity
ADSK
ADSK
RMD
RMD
Q2 26
0.11×
Q1 26
0.82×
Q4 25
0.86×
0.06×
Q3 25
0.92×
0.07×
Q2 25
0.88×
0.11×
Q1 25
0.88×
0.12×
Q4 24
0.88×
0.13×
Q3 24
0.93×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADSK
ADSK
RMD
RMD
Operating Cash FlowLast quarter
$989.0M
Free Cash FlowOCF − Capex
$972.0M
FCF MarginFCF / Revenue
49.7%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
3.13×
TTM Free Cash FlowTrailing 4 quarters
$2.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADSK
ADSK
RMD
RMD
Q2 26
Q1 26
$989.0M
Q4 25
$439.0M
$339.7M
Q3 25
$460.0M
$457.3M
Q2 25
$564.0M
$538.8M
Q1 25
$692.0M
$578.7M
Q4 24
$209.0M
$308.6M
Q3 24
$212.0M
$325.5M
Free Cash Flow
ADSK
ADSK
RMD
RMD
Q2 26
Q1 26
$972.0M
Q4 25
$430.0M
$311.2M
Q3 25
$451.0M
$414.4M
Q2 25
$556.0M
$508.2M
Q1 25
$678.0M
$557.9M
Q4 24
$199.0M
$288.0M
Q3 24
$203.0M
$307.7M
FCF Margin
ADSK
ADSK
RMD
RMD
Q2 26
Q1 26
49.7%
Q4 25
23.2%
21.9%
Q3 25
25.6%
31.0%
Q2 25
34.0%
37.7%
Q1 25
41.4%
43.2%
Q4 24
12.7%
22.5%
Q3 24
13.5%
25.1%
Capex Intensity
ADSK
ADSK
RMD
RMD
Q2 26
Q1 26
0.9%
Q4 25
0.5%
2.0%
Q3 25
0.5%
3.2%
Q2 25
0.5%
2.3%
Q1 25
0.9%
1.6%
Q4 24
0.6%
1.6%
Q3 24
0.6%
1.5%
Cash Conversion
ADSK
ADSK
RMD
RMD
Q2 26
Q1 26
3.13×
Q4 25
1.28×
0.87×
Q3 25
1.47×
1.31×
Q2 25
3.71×
1.42×
Q1 25
2.28×
1.59×
Q4 24
0.76×
0.90×
Q3 24
0.75×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADSK
ADSK

Sales Channel Through Intermediary$602.0M31%
Auto CA Dand Auto CADLT Family$478.0M24%
Manufacturing$381.0M19%
Make$218.0M11%
Other$130.0M7%
Other Research And Development$129.0M7%
Maintenance$8.0M0%

RMD
RMD

Segment breakdown not available.

Related Comparisons